COMPARISON OF POST OPERATIVE NASAL PATENCY FOLLOWING SUBMUCOSAL DIATHERMY OF INFERIOR TURBINATE WITH MICRODEBRIDER-ASSISSTED TURBINOPLASTY
Objective: The objective of this study was to compare post-operative nasal patency following microdebriderassisted turbinoplasty with submucosal diathermy in patients of hypertrophic inferior turbinates.
Study Design: Randomized control trial.
Place and Duration of Study: ENT Department Combined Military Hospital Lahore from Aug 2013 to Feb 2014.
Material and Methods: This randomized control trial was conducted at the ENT Department Combined Military Hospital, Lahore for six months from: 20 Aug 2013 to 20 Feb 2014. After taking permission from hospital ethical committee one hundred and twenty patients of inferior turbinate enlargement fulfilling the inclusion and exclusion criteria were selected through non-probability sampling. Group A underwent submucosal diathermy of inferior turbinate, while group B had microdebrider-assisted turbinoplasty. Patients in both groups were given tab co-amoxiclav 625 mg 8 hourly, tab mefenamic acid 500 mg 8 hourly and tab chlorpheniramine maleate 4 mg 12 hourly for 5 days. Nasal packs were removed after 48 hours. Patients were advised regular nasal toilet.
Results: Among 120 cases (60 in each group), mean age was calculated as 33.38 ± 10.27 and 33.63 ± 10.78 in groupA and B respectively. In group-A, 60% (n=36) were males and 40% (n=24) were females while in Group-B 53.33% (n=32) were males and 46.67% (n=28) were females. Comparison of post-operative nasal patency following microdebrider-assisted turbinoplasty was done with that of submucosal diathermy, which showed that 73.33% (n=44) in Group-A and 93.33% (n=56) in Group-B had good nasal obstruction relief while 26.67% (n=16) in groupA and 6.67% (n=4) in Group-B had no good nasal obstruction relief. A p value was calculated as 0.003.
Conclusion: Post-operative nasal patency was better outcome following microdebrider-assisted turbinoplasty as compared to submucosal diathermy among two groups of patients.